**Charity Registration No. 1089588 (England and Wales)**
**Charity Registration No. SC446344 (Scotland) Company Registration No. 04267454 (England and Wales)**
## **METABOLIC SUPPORT UK**
**ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021**
## **METABOLIC SUPPORT UK**
## **LEGAL AND ADMINISTRATIVE INFORMATION**
## **Trustees**
Dr R E Pugh MBChB FRCP Mr P J Roper MIET CEng BSC Hons Mr J O'Hara Msc Mr A Johnson Dr R Vara Dr E H Davies Mr B Hopkins Mr C Lander (Appointed 2 September 2020)
**Charity number (England and Wales)** 1089588 **Charity number (Scotland)** SC446344 **Company number** 04267454 **Registered office** Unit 11-12 Gwenfro Technology Park Croesnewydd Road Wrexham LL13 7YP **Independent examiner** McLintocks (NW) Limited 2 Hilliards Court Chester Business Park Chester Cheshire CH4 9PX
## **METABOLIC SUPPORT UK**
## **CONTENTS**
||**Page**|
|---|---|
|Trustees' report|1 - 6|
|Independent examiner's report|7|
|Statement of financial activities|8|
|Balance sheet|9|
|Notes to the financial statements|10 - 18|
## **METABOLIC SUPPORT UK**
## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
The trustees present their report and financial statements for the year ended 31 March 2021.
The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended) and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".
## **Objectives and activities**
The charity's primary aims are to:
- The relief of children, young adults, family members and carers affected by metabolic diseases in particular by means of:
- i. Providing for the same group, an information, advice and support service.
- ii. Putting the same group into contact with each other for their mutual benefit, help and support.
- iii. The provision for grants and allowances for the same group and in addition to hospitals, homes or institutions, as shall from time to time be determined, for the purposes of medical treatment, care and relief from suffering.
- The relief of adults who are affected by metabolic diseases by the provision of support and services which are not otherwise provided by any other metabolic disease group in England, as the trustees think fit.
- The education of Health care professionals, other professionals and the general public about metabolic diseases.
- To provide medical research into metabolic diseases and their diagnosis.
The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake.
## **Achievements and performance**
Metabolic Support UK is an umbrella patient advocacy organisation founded in 1981, supporting and advocating for people living with Inherited Metabolic Disorders (IMDs) and their caregivers.
There are approximately 30,000 people in the UK today living with one of over 500 IMDs. These are rare, lifelong genetic disorders caused by an enzyme deficiency affecting the metabolic pathway which if undiagnosed or untreated, can cause irreversible complications, or sadly even death.
Focusing specifically on the rarest of the IMDs, those which have no other patient organisation or support group, Metabolic Support UK delivers a wide range of support and advocacy services to address unmet needs. Using qualitative and quantitative data generated via various methodologies, our small dedicated team works to proactively identify priority needs and develop evidence-based outputs and programmes to ensure the maximum impact for individual patients, collective patient communities and the wider IMD community.
Our vision for the future: By 2030, Metabolic Support UK wants to see advances across all care and services for the IMD community; this includes early diagnosis, informed and empowered patients, and access to the treatments and services that are available to support families living with these conditions to enjoy a better quality of life.
- 1 -
## **METABOLIC SUPPORT UK**
## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **Covid-19 Response**
During this year our work was heavily influence by the need to respond to the Covid-19 pandemic. We responded with a number of specific projects that included:
- Produced 10 Covid Patient Insight videos, demonstrating the impact the Pandemic has had on patients and families living with Inherited Metabolic Disorders. These will be a powerful tool in advocating for patients on CRG and in informing collaborative awareness raising campaigns and wider policy issues.
- Developed a Covid resource hub on our website which has received over 15,000 visitors to date. The resource hub ensures patients are kept up to date and informed with accessible, factual and reliable information.
- Hosted 3 covid themed webinars and produced 13 self-care when shielding and social distancing videos. These videos provided reassurances and support to our patient community during the national lockdowns.
- Responded to over 600 Covid-19 related enquiries, alleviating the pressure on our Metabolic Centre colleagues in the NHS
- Introduced our popular Virtual Coffee and Chat which run fortnightly and provide a space for our communities to connect and chat online.
Whilst our immediate priority was to respond to the emerging and ever-changing needs and challenges in light of the coronavirus pandemic, it was also important to keep our long term strategic objectives at the forefront of the businesses and services that we create and deliver. We want to ensure that once the pandemic is over, the communities that we support and engage with, remain together and engaged with us. It is our aim that we represent a strong unified patient voice and ensure that patients and families living with rare diseases are not forgotten during and in the aftermath of the pandemic. Therefore we are driving forward with collaborative initiatives with other patient organisations. It is essential that we combine our knowledge and understanding of the impact of Covid-19 on our rare disease patient populations so we can better advocate for the needs of our communities together. With the rare disease framework launch, NICE methods review, review of medicines and other policy items, it is vital that patients have a platform to participate in issues that affect them. To support our communities, we had to upskill our team and provide trusted and up to date support for our community.
## **Organisational Development**
During this year we went through some personnel changes as a response to the Covid-19 pandemic and to better structure the future of Metabolic Support UK in line with our ten year strategy. Our CEO, Lindsay Weaver resigned during this financial year and the board began external recruitment for a new CEO, with Kirsty Hoyle appointed in August 2021.
- 2 -
## **METABOLIC SUPPORT UK**
## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **Achievements and Performance**
Metabolic Support UK continues to deliver support and advocacy for patient and their families, from point of diagnosis, through all stages of the patient’s journey to bereavement and beyond. With over 500 extremely rare conditions, the spectrum of unmet need is wide-ranging and diverse.
Our work this year began with our Covid-19 response. The pandemic affected the whole IMD patient community, many of whom were considered extremely clinically vulnerable and increased demand for the charity’s support services. The staff team and Board immediately mobilised to respond to the crisis, supporting staff to work from home, increasing digital presence, and upskilling in the technology required to deliver its projects virtually. In the first two months of 2020-21 we:
- Directly supported 142 patients and their families through our individual enquiries with an average resolution time of 15 hours.
- Sent communications to over 25k people with 64% direct to patients and their families
- Had over 4,000 views on our online Covid-19 resources.
Alongside this immediate response, and against a background of the continuing pandemic and organisational change, we continued to offer our core services – in line with our strategy – throughout 2020/21:
## **Information, Education and Connecting Patients**
o First online conference attended by over 100 patients, families, healthcare professionals, industry representatives and other IMD stakeholders.
o Connected over 50 families worldwide via Metabolic Connect (peer support programme) offering and receiving peer support to reduce isolation and share experiences.
- Supported over 350 Individual Enquiries through our Information and Advice Line
o Commenced the building of eight disorder-specific patient communities.
- Launched our ‘Jargon Busters’ video series
## **Awareness Raising and Visibility**
- We were a member of the ARDENT (Action for Rare Disease Empowerment) project working group, evidencing the impact of Covid-19 on the rare disease community with partners such as the Cambridge Rare Disease Network.
- We worked in collaboration with other stakeholders to build our profile and partnerships including our work on the COVID-19 Vaccine webinar in collaboration with the Lysosomal Storage Disorders Patient Collaborative and the British Inherited Metabolic Disease Group.
- Our team represented the charity at a variety of meetings including the Metabolic CRG meetings, IMD Screening Advisory Group meetings, Specialist Healthcare Alliance meetings, and APPG for Access to Medicines and Medical Devices meetings.
## **Advocacy**
- Metabolic Support UK is recognised as the leading patient advocate group for all Inherited Metabolic Disorders in the UK, and holds stakeholder positions with NICE, the UK Screening Committee and other groups. 2020/21 positions include:
- IMD Newborn Screening Advisory Committee
- Metabolic Clinical Referencing Group
- In September 2020 we launched our work with Breaking Down Barriers, sharing our new Patient Insight Series and recruiting a BAME Ambassador and putting in measures to ensure we capture ethnicity and religion of patients in our data to better understand and serve all communities
- We joined the working group for Rare QOL, a social prescribing working group for rare disease communities.
- Supported the development of a new disease-specific patient community organisation, Thrive PKD, with one of our trustees.
- 3 -
## **METABOLIC SUPPORT UK**
## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **Strategic Implementation**
2020/21 was the first year of our implementation for our new strategy and ten-year plan, approved by the board in March 2020; a strategy designed to adapt to fast-paced changes in the rare disease landscape, deliver effective and impactful support services to meet increasing demand, and secure the long-term sustainability of the charity. This was put to the test immediately in this year by the Covid-19 pandemic. We structured support for our community under the four key strategic pillars of our strategy during this very difficult year:
Our team provided unrivalled frontline emotional and practical **Individual Support** to patients and caregivers via our experienced and qualified support team.
We focused on **Building Patient Communities** for new rare diseases, expanding opportunities for peer to peer support **.**
Patients were offered increased opportunity to contribute to the decisions around access to care or treatment through our **Empowerment** work.
Our work gathering data and evidence from our communities during this year has advanced our patient’s opportunities for meaningful **Advocacy.**
## Fundraising
Metabolic Support UK continued to implement the 2018 fundraising strategy which aimed to diversifying its income streams. The impact of Covid-19 meant that community fundraising was more of a challenge but we were successful in securing a National Lottery Covid-19 grant of £93k. The organisations that provided funding towards Metabolic Support’s activities in 2020/21 include:
- National Lottery Covid-19 Response Fund
- Sylvia Adams Charitable Trust
- Bionical
- Alexion
- Chiesi
- Moderna
- Alynlam
- Kyowa Kirin
- Agios
- Ultragenyx
- Amicus
- Takeda
- Audentes
- Immedica
- Reneo
Metabolic Support UK’s community of fundraisers and donors continued to fundraise via a number of different activities across 2020-21 including remote fundraising. We continue to be grateful for the legacies received from our supporters
- 4 -
## **METABOLIC SUPPORT UK**
## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **Financial review**
## Financial Position at Year End
At the year end, Metabolic Support UK’s accounts showed a surplus made up of unrestricted funds. This is the due to the sale of a property and legacies received. Due to the uncertainty on the impact the covid-19 pandemic will have on the charity’s income generation in 2021/22 and beyond, the priorities for the next financial year will be to preserve as much of the reserves as possible to ensure the future sustainability of the charity, by:
- Stabilising expenditure and focussing on digital service delivery and outputs
- Retaining and supporting the smaller existing staff team to deliver the strategy with the support of freelancers
- Further diversifying income streams to include trusts and foundations
## **Financial review**
The Board of Trustees of Metabolic Support UK continue monitor the financial health of the charity.
The unrestricted reserves held by the charity is currently £584,393 higher than the policy of 6 months running costs (approximately £250,000) due to the sale of the property and legacies received. The Board committed to the planned investment of the funds into the development of the charity in the short to medium term, to create future suitability and increase the positive impact on the lives of those who are affected by Inherited Metabolic Disorders now and in the future.
The property that formed the charity’s headquarters in Crewe was sold in the 2020/21 financial year.
At year ending March 2021, Metabolic Support UK’s funds are held in the Co-operative Bank.
The charity’s assets are considered to be adequate to fulfil our obligations in relation to future financial commitments. As the majority of our assets are liquid, no significant delays or shortfalls are anticipated in realising these assets into cash.
The trustees has assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks.
## **Structure, governance and management**
The charity is a company limited by guarantee .
That charity is governed by its Memorandum and Articles of Association and the said Memorandum and Articles of Association were amended in January 2014 and the relevant amendments agreed with the Charity Commission for England and Wales and posted with Companies House.
The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:
Dr R E Pugh MBChB FRCP Mr P J Roper MIET CEng BSC Hons Ms J R Godfrey (Resigned 2 December 2020) Mr J O'Hara Msc Mr A Johnson Dr R Vara Dr E H Davies Mr B Hopkins Mr C Lander (Appointed 2 September 2020)
- 5 -
## **METABOLIC SUPPORT UK**
## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **Recruitment and appointment of new trustees**
New trustees are recruited and appointed by the existing trustees as vacancies arise on the Board.
## **Induction and training of trustees**
New trustees are provided with information about the charity and its work and their role and responsibilities as trustees.
The trustees' r eport was approved by the Board of Trustees.
## **Dr E H Davies**
Trustee Dated: 28 January 2022
- 6 -
## **METABOLIC SUPPORT UK**
## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF METABOLIC SUPPORT UK**
I report to the trustees on my examination of the financial statements of Metabolic Support UK (the charity) for the year ended 31 March 2021.
## **Responsibilities and basis of report**
As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities and Trustee Investment (Scotland) Act 2005 (the 2005 Act), the Charities Accounts (Scotland) Regulations 2006 (as amended) and the Companies Act 2006 (the 2006 Act). You are satisfied that the financial statements of the charity are not required by charity or company law to be audited and have chosen instead to have an independent examination.
Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity’s financial statements carried out under section 44 (1) ( c) of the 2005 Act and section 145 of the Charities Act 2011 (the 2011 Act) . In carrying out my examination I have followed the requirements of Regulation 11 of the Charities Accounts (Scotland) Regulations 2006 (as amended) and all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
Since the charity is required by company law to prepare its accounts on an accruals basis and is registered as a charity in Scotland your examiner must be a member of a body listed in Regulation 11(2) of the Charities Accounts (Scotland) Regulations 2006 (as amended). I confirm that I am qualified to undertake the examination because I am a member of ICAEW, which is one of the listed bodies.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
- 1 accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act and Regulation 4 of the 2006 Accounts Regulations; or
- 2 the financial statements do not accord with those records; or
- 3 the financial statements do not comply with the accounting requirements of Regulation 8 of the Charities Accounts (Scotland) Regulations 2006 (as amended) and do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
- 4 the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Michael Caputo FCA McLintocks (NW) Limited 2 Hilliards Court Chester Business Park Chester Cheshire CH4 9PX
Dated: 28 January 2022
- 7 -
## **METABOLIC SUPPORT UK**
## **STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT** _**FOR THE YEAR ENDED 31 MARCH 2021**_
|**Unrestricted**
**Restricted**
**funds**
**funds**
**2021**
**2021**
**Notes**
**£**
**£**
**Income and endowments from:**
Donations and legacies
**3**
327,583
-
Charitable activities
**4**
31,591
-
Investments
**5**
1,404
-
Other income
**6**
128,884
-
**Total income**
489,462
-
**Expenditure on:**
Raising funds
**7**
-
-
Charitable activities
**8**
384,784
-
Other
**12**
15,534
-
**Total resources**
**expended**
400,318
-
**Net incoming/(outgoing)**
**resources**
89,144
-
**Other recognised gains and losses**
Revaluation of tangible
fixed assets
12,240
-
**Net movement in funds**
101,384
-
Fund balances at 1
April 2020
483,009
12,504
**Fund balances at 31**
**March 2021**
584,393
12,504|**Total**Unrestricted
Restricted
Total
funds
funds
**2021**
2020
2020
2020
**£**
**£**
**£**
**£**
327,583
302,082
-
302,082
31,591
56,330
2,133
58,463
1,404
5,936
-
5,936
128,884
962
-
962
489,462
365,310
2,133
367,443
-
147,716
-
147,716
384,784
361,345
5,000
366,345
15,534
-
-
-
400,318
509,061
5,000
514,061
89,144
(143,751)
(2,867)
(146,618)
12,240
(50,000)
-
(50,000)
101,384
(193,751)
(2,867)
(196,618)
495,513
676,760
15,371
692,131
596,897
483,009
12,504
495,513|
|---|---|
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities.
The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
- 8 -
## **METABOLIC SUPPORT UK**
## **BALANCE SHEET**
## _**AS AT 31 MARCH 2021**_
|**Notes**
**Fixed assets**
Tangible assets
**13**
**Current assets**
Cash at bank and in hand
**Creditors: amounts falling due within**
**one year**
**14**
Net current assets
**Total assets less current liabilities**
**Income funds**
Restricted funds
Unrestricted funds
General unrestricted funds
Revaluation reserve|**2021**
**£**
601,047
(4,150)
584,393
-|**£**
-
596,897
596,897
12,504
584,393
596,897|**2020**
**£**
398,026
(10,031)
495,249
(12,240)|**£**
107,518
387,995
495,513
12,504
483,009
495,513|
|---|---|---|---|---|
The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 March 2021.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the Trustees on 28 January 2022
Dr E H Davies **Trustee**
## **Company Registration No. 04267454**
- 9 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **1 Accounting policies**
## **Charity information**
Metabolic Support UK is a private company limited by guarantee incorporated in England and Wales. The registered office is Unit 11-12 Gwenfro, Technology Park, Croesnewydd Road, Wrexham, LL13 7YP.
## **1.1 Accounting convention**
The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006, the Charities and Trustee Investment (Scotland) Act 2005, the Charities Accounts (Scotland) Regulations 2006 (as amended) and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2016). The charity is a Public Benefit Entity as defined by FRS 102.
The charity has taken advantage of the provisions in the SORP for charities applying FRS 102 Update Bulletin 1 not to prepare a Statement of Cash Flows.
The financial statements are prepared in sterling , which is the functional currency of the charity . Monetary a mounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
## **1.2 Going concern**
At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
## **1.3 Charitable funds**
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.
## **1.4 Incoming resources**
Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.
- 10 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **1 Accounting policies**
**(Continued)**
## **1.5 Tangible fixed assets**
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Land and buildings nil Plant and machinery 33% straight line Fixtures, fittings & equipment 15% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in net income/(expenditure) for the year.
## **1.6 Impairment of fixed assets**
At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any ) .
## **1.7 Cash and cash equivalents**
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
## _**Basic financial assets**_
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
## _**Basic financial liabilities**_
Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future p aymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
## _**Derecognition of financial liabilities**_
Financial liabilities are derecognised when the charity ’s contractual obligations expire or are discharged or cancelled.
- 11 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **1 Accounting policies**
**(Continued)**
## **1.8 Employee benefits**
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
## **2 Critical accounting estimates and judgements**
In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
## **3 Donations and legacies**
||**Unrestricted**|Total|
|---|---|---|
||**funds**||
||**2021**|2020|
||**£**|£|
|Donations and gifts|327,583|302,082|
- 12 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **4 Charitable activities**
||**Fundraising**|**Membership**|**Total**|**Total**|
|---|---|---|---|---|
||**income**||**2021**|**2020**|
||**2021**|**2021**|||
||**£**|**£**|**£**|**£**|
|Sales within charitable activities|31,591|-|31,591|58,463|
|Analysis by fund|||||
|Unrestricted funds|31,591|-|31,591|56,330|
|Restricted funds|-|-|-|2,133|
|**For the year ended 31 March 2020**|||||
|Unrestricted funds|51,238|5,092||56,330|
|Restricted funds|2,133|-||2,133|
||53,371|5,092||58,463|
|**Investments**|||||
|||**Unrestricted**Unrestricted|||
||||**funds**|funds|
||||**2021**|2020|
||||**£**|£|
|Interest receivable|||1,404|5,936|
|**Other income**|||||
|||**Unrestricted**Unrestricted|||
||||**funds**|funds|
||||**2021**|2020|
||||**£**|£|
|Other income|||8,467|962|
|Coronavirus job retention scheme|||27,607|-|
|National Lottery Coronavirus grant|||92,810|-|
||||128,884|962|
## **5 Investments**
## **6 Other income**
- 13 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **7 Raising funds**
|Fundraising and publicity
Seeking donations, grants and legacies
Other fundraising costs
Staff costs
Fundraising and publicity|**Total**Unrestricted
funds
**2021**
2020
**£**
£
-
8,095
-
38,429
-
101,192
-
147,716
-
147,716|
|---|---|
- 14 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **8 Charitable activities**
|**Direct**
**charitable**
**activities**
**Restricted**
**expenditure**
**2021**
**2021**
**£**
**£**
Staff costs
259,354
-
Depreciation and impairment
7,518
-
Rent, rates and cleaning
22,629
-
Insurance
1,632
-
Light & heat
3,791
-
Repairs & maintenance
2,045
-
Printing, postages and stationery
729
-
Telephone and IT costs
27,887
-
Meetings travel & accommodation
-
-
Sundries
2,943
-
Recruitment fees
10,000
-
Bank charges
1,047
-
Projects
24,266
-
Equipment hire
6,066
-
Marketing
1,458
-
Professional fees
5,992
-
377,357
-
Share of support costs (see note 9)
3,444
-
Share of governance costs (see note 9)
3,983
-
384,784
-
**Analysis by fund**
Unrestricted funds
384,784
-
Restricted funds
-
-
**For the year ended 31 March 2020**
Unrestricted funds
361,345
-
Restricted funds
-
5,000
361,345
5,000|**Total**
**2021**
**£**
259,354
7,518
22,629
1,632
3,791
2,045
729
27,887
-
2,943
10,000
1,047
24,266
6,066
1,458
5,992
377,357
3,444
3,983
384,784
384,784
-|**Total**
**2020**
**£**
185,466
10,899
39,633
2,829
4,416
1,699
3,349
22,052
15,061
1,131
-
2,264
25,352
3,071
23,464
-
340,686
-
25,659
366,345
361,345
5,000
361,345
5,000
366,345|
|---|---|---|
- 15 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
## **9 Support costs**
|**Support**
**costs**
**Governance**
**costs**
**£**
**£**
Staff costs
-
-
Human resource fees
3,444
-
Independent examination
-
2,100
Accountancy
-
1,883
Trustees meeting expenses
-
-
3,444
3,983
Analysed between
Charitable activities
3,444
3,983|**2021**
**£**
-
3,444
2,100
1,883
-
7,427
7,427|2020
£
18,596
-
2,100
-
4,963
25,659
25,659|
|---|---|---|
## **10 Trustees**
None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year.
## **11 Employees**
The average monthly number of employees during the year was:
|Charitable
Fundraising
Administration
Total
**Employment costs**
Wages and salaries|**2021**
**Number**
5
2
1
8
**2021**
**£**
259,354|**2020**
**Number**
9
2
1
12
**2020**
**£**
305,254|
|---|---|---|
Total remuneration for the key management personnel of the charity was £88,677.
There were no employees whose annual remuneration was £60,000 or more.
- 16 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
|**12**
**Other**
**Unrestricted**
**funds**
**2021**
Net loss on disposal of tangible fixed assets
15,534
15,534|Total
£
2020
-
-|
|---|---|
## **13 Tangible fixed assets**
|**13**|**Tangible fixed assets**|||||
|---|---|---|---|---|---|
|||**Land and**|**Plant and**|**Fixtures,**|**Total**|
|||**buildings**|**machinery**|**fittings &**||
|||||**equipment**||
|||**£**|**£**|**£**|**£**|
||**Cost**|||||
||At 1 April 2020|100,000|28,472|9,722|138,194|
||Disposals|(100,000)|-|-|(100,000)|
||At 31 March 2021|-|28,472|9,722|38,194|
||**Depreciation and impairment**|||||
||At 1 April 2020|-|21,747|8,929|30,676|
||Depreciation charged in the year|-|6,725|793|7,518|
||At 31 March 2021|-|28,472|9,722|38,194|
||**Carrying amount**|||||
||At 31 March 2020|100,000|6,725|793|107,518|
|**14**|**Creditors: amounts falling due within one year**|||||
|||||**2021**|**2020**|
|||||**£**|**£**|
||Other taxation and social security|||2,051|7,046|
||Accruals and deferred income|||2,099|2,985|
|||||4,150|10,031|
## **15 Retirement benefit schemes**
The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.
- 17 -
## **METABOLIC SUPPORT UK**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 MARCH 2021**_
|**16**
**Analysis of net assets between funds**
**Unrestricted**
**Restricted**
**2021**
**2021**
**£**
**£**
Fund balances at 31
March 2021 are
represented by:
Tangible assets
-
-
Current assets/
(liabilities)
584,393
12,504
584,393
12,504|**Total**Unrestricted
Restricted
**2021**
2020
2020
**£**
£
£
-
107,518
-
596,897
375,491
12,504
596,897
483,009
12,504|Total
2020
£
107,518
387,995
495,513|
|---|---|---|
## **17 Related party transactions**
There were no disclosable related party transactions during the year (2020 - none) .
- 18 -